Board of Directors
Chariman since November of 2016. Anders Lönner is Executive Chairman of the Board of Directors of Karo Pharma AB. Previous experience as President and CEO, board member of Valeant Pharmaceuticals International Inc., President for Astra Läkemedel with responsibilities including Astra’s Scandinavian subsidiary, President for Karo Bio AB and Chairman of Läkemedelsindustriföreningen (LIF). Anders Lönner is also medicine Honorary Doctors at Karolinska Institutet.
Executive Vice Chairman of the Board since 2016, Member of the Board since 1999. CEO of Oasmia and one of the founders of the company. Has extensive experience in coordination of research projects and strategic development of global intangible assets. Also Chairman of the Board in Qdoxx Pharma AB and Oasmia Animal Health AB.
Chairman of the Board 2000-2011. Member of the Board since 2011. About 40 years' experience as CEO and partner in a number of small and mid-sized businesses, mainly within trade. Extensive experience in international trade and production. Has been very active within trade branch associations. Deputy Member of the Board for the last 5 years in Fruges AB (on-going) and Member of the Board in the Arken stores (ended).
Member since autumn 2013. Served as Vice President and CFO of Q-Med AB since February 2008. Mr. Kotsinas has also served as Chief Financial Officer at Life Europe AB and 3 Scandinavia (Mobile Operator Tre). He served as a Vice President at Investor AB and has also worked at Ericsson. He is a Board Member of several companies. Alexander has a Master of Science from the Royal Institute of Technology in Applied Physics and a Bachelor of Science from Handelshögskolan in Stockholm.
Member since 2015. Lars has an MSc in Accounting and Finance and has previously worked in the management of a number of successful companies. Hans has been the CEO of Arken Zoo and Hidden Dinosaur among others. He also has extensive experience of working as a board member and chairman in FDT AB, Master Design AB and Swedish Franchise among others.